Vaccine-makers And Ebola: Giving It A Shot

IN MAY 2013 GlaxoSmithKline (GSK), a British pharmaceuticals firm, bought a small Swiss vaccine-maker for $325m. It acquired Okairos because it had the technology to create vaccines that stimulate stronger than normal immune responses. In a press release Okairos said the deal included a “small number of early-stage assets”.That passing remark turned out to be a big deal.

Topics:  glaxosmithkline gsk    british   swiss   world health organisation who    august   ebola   who two   gsk s   newlink genetics   american   west africa   johnson   gsk   okairos   who   vaccines   work   candidates   small   year   firm   deal   included   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News